News – Page 565 – Endpoints News

Novartis' Sandoz settles with Novo Nordisk for 2024 launch of third Victoza generic

4 years ago

Blasting Russia’s Ukraine invasion, Roche ships more meds and diagnostics to war-torn country

4 years ago

Amid inspection and recall woes, Aurobindo to shut down NJ site in April

4 years ago

FDA approved? Yes, but quite a few pharmas leave out the messy details on accelerated approval

4 years ago

Pfizer yanks blood pressure meds amidst ongoing, industry-wide nitrosamine problems

4 years ago

Teva suffers setback on in-house asthma program as a PhII study is halted early due to futility

4 years ago

Vertex's R&D team maps a straight course to the FDA as it lays out pivotal search for another blockbuster

4 years ago

Schumer pledges vote on $35 insulin caps next month as other pricing reforms remain on hold for now

4 years ago

The first big test of Pfizer’s Arena buyout clears a PhIII in bid to catch up to Zeposia

4 years ago

Merck development chief Roy Baynes is stepping out and reuniting with Roger Perlmutter at a biotech startup

4 years ago

Moderna hits primary endpoint in Covid vax trial for youngest kids, but efficacy tops out at under 45%

4 years ago

Another small biotech watches its lead drug implode as its stock price tanks

4 years ago

Ahead of FDA committee to discuss new ALS drug, the jury remains out on how much benefit is enough for approval

4 years ago

PhIII failure triggers layoffs, spending cuts and warning of 'dissolution' for single-minded biotech

4 years ago

Greg Verdine will have many new C-suite friends at fungus biotech LifeMine after GSK-fueled $175M round

4 years ago

Generic drug industry calls on FTC to dig into monopsony power among buyers, PBMs

4 years ago

A look into the 340B explosion of growth as Gilead and J&J join more than a dozen peers setting their own terms

4 years ago

As branded drug sales surge, analysts predict China market will remain 'very attractive'

4 years ago

Fujifilm expands C&G therapy options with acquisition of recombinant protein maker

4 years ago

Teva reaches $100M settlement with Rhode Island for decade of anti-narcotic drugs and $21M cash

4 years ago

Serum Institute lands another vaccine collaboration, pushing business beyond the pandemic

4 years ago

MarketingRx roundup: HHS’ vaccination ‘We Can’ campaign blanketed US; Moderna takes top PR honors

4 years ago

Hunt for Russian oligarch’s billions leads to biotech activist investor Alex Denner’s fund — report

4 years ago

Big Pharma ad spending edges toward $7B with Sanofi, Regeneron and Novo Nordisk leading the way

4 years ago

First page Previous page 562 563 564565566 567 568 Next page Last page